Thus, plasma KP levels were measured among the following patient groups, as previously described30 (see Table 1 for patient demographics): (1) newly diagnosed, nonmetastatic TNBC (early disease); (2) metastatic TNBC (advanced disease), and (3) healthy subjects (no prior history of breast cancer). Here, NPPA is linked to breast carcinoma.